Metformin for Longevity & Prediabetes: Can One Medication Help You Live Healthier, Longer?

In the world of preventive medicine and longevity, few medications have generated as much excitement as metformin. Originally developed to treat type 2 diabetes, metformin has become one of the most widely prescribed medications worldwide—and today, researchers are exploring whether its benefits extend far beyond blood sugar control.

At Morrell Wellness, our philosophy is simple: optimize health before disease develops. If you’ve been told you have prediabetes, insulin resistance, or you’re interested in evidence-based longevity medicine, metformin may be worth discussing with your physician.

What Is Metformin?

Metformin is an oral medication that has been used safely for more than 60 years to improve the body’s response to insulin. It works primarily by reducing glucose production in the liver, improving insulin sensitivity, and helping the body use glucose more efficiently.

Unlike many diabetes medications, metformin does not typically cause low blood sugar when used alone and has a long-established safety profile.

⸻

What Is Prediabetes?

Prediabetes occurs when blood sugar levels are higher than normal but not yet high enough to meet the criteria for type 2 diabetes.

You may be considered prediabetic if you have:

Hemoglobin A1c between 5.7% and 6.4%

Fasting blood glucose between 100–125 mg/dL

An abnormal glucose tolerance test

Without intervention, many individuals with prediabetes will eventually develop type 2 diabetes. The encouraging news is that progression is often preventable.

⸻

Does Metformin Prevent Diabetes?

Yes. One of the largest and most influential studies ever conducted on diabetes prevention—the Diabetes Prevention Program (DPP)—demonstrated that metformin significantly reduced the risk of developing type 2 diabetes.

The study found:

Lifestyle modification reduced diabetes risk by 58%

Metformin reduced diabetes risk by 31%

While healthy nutrition, regular exercise, and weight management remain the foundation of diabetes prevention, metformin provides an additional evidence-based option for individuals at higher risk.

⸻

Who Benefits Most?

Current medical guidelines suggest metformin may be especially beneficial for people who have:

Prediabetes

Insulin resistance

A body mass index (BMI) of 35 or higher

A history of gestational diabetes

Rising A1c despite lifestyle changes

Features of metabolic syndrome

For many patients, combining healthy lifestyle habits with metformin provides the greatest long-term benefit.

⸻

Why Is Everyone Talking About Metformin for Longevity?

Beyond diabetes prevention, researchers have discovered that metformin appears to influence several biological pathways involved in aging.

Potential mechanisms include:

Improved insulin sensitivity

Reduced chronic inflammation

Activation of AMPK, often called the body’s “metabolic master switch”

Reduced oxidative stress

Improved mitochondrial function

Healthier cellular energy metabolism

Indirect reduction of mTOR signaling, a pathway linked to aging

These effects have made metformin one of the most studied medications in longevity medicine.

⸻

Can Metformin Help You Live Longer?

This is the question researchers are actively working to answer.

Observational studies have found that people taking metformin often experience:

Lower rates of cardiovascular disease

Lower overall mortality

Reduced rates of certain cancers

Possible protection against cognitive decline

While these findings are encouraging, they do not prove that metformin extends lifespan in otherwise healthy individuals.

Large clinical trials are underway to determine whether metformin can truly slow biological aging and increase healthy years of life.

At this time, the evidence is promising—but not yet definitive..

⸻

Is Metformin Right for You?

Metformin may be an excellent option for individuals who have:

Prediabetes

Insulin resistance

Metabolic syndrome

Polycystic ovary syndrome (PCOS)

Elevated risk of developing type 2 diabetes

It may also be appropriate for select patients interested in physician-guided longevity strategies, although its role in healthy aging continues to be studied.

At Morrell Wellness, we believe longevity medicine should be personalized, evidence-based, and focused on optimizing health—not simply treating disease.

⸻

The Bottom Line

Metformin remains one of the most thoroughly studied medications available for improving metabolic health and preventing type 2 diabetes. While its potential role in longevity is exciting, the strongest evidence today supports its use for individuals with insulin resistance and prediabetes.

If you’re interested in learning whether metformin could be part of your personalized wellness plan, our physicians can review your health history, laboratory results, and goals to determine the most appropriate approach.

Ready to optimize your metabolic health?

Schedule a consultation with Morrell Wellness and discover whether a personalized longevity and metabolic health plan is right for you.

References:

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.

Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15 years. Lancet Diabetes Endocrinol. 2015;3(11):866-875.

Diabetes Prevention Program Research Group. Effect of metformin and lifestyle interventions on mortality over 21 years. Diabetes Care. 2022;45(12):2921-2930 (tel:2921-2930).

American Diabetes Association Professional Practice Committee. Prevention or delay of type 2 diabetes and associated comorbidities: Standards of Care in Diabetes—2026. Diabetes Care. 2026.

Knowler WC, Barrett-Connor E, Fowler SE, et al. Ten-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686.

Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis. Ageing Res Rev. 2017;40:31-44.

Kulkarni AS, Gubbi S, Barzilai N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 2020;32(1):15-30.

Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab. 2016;23(6):1060-1065.

Barzilai N, et al. The Targeting Aging with Metformin (TAME) Trial: Scientific rationale and study design. Clin Geriatr Med. 2020;36(4):553-566.

Bannister CA, Holden SE, Jenkins-Jones S, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched controls. Diabetes Obes Metab. 2014;16(11):1165-1173.

Saisho Y. Metformin and inflammation: Its potential beyond glucose lowering. Diabetol Int. 2015;6:1-11.

Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: An overview. Clin Sci (Lond). 2012;122(6):253-270.

Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577-1585.

Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: From mechanisms of action to therapies. Cell Metab. 2014;20(6):953-966.

Flory J, Lipska K. Metformin in 2019. JAMA. 2019;321(19):1926-1927.

American Association of Clinical Endocrinology. Clinical Practice Guideline for Developing a Diabetes Mellitus Comprehensive Care Plan. Endocr Pract. 2022.

Nathan DM, Buse JB, Kahn SE, et al. Rationale and design of the Glycemia Reduction Approaches in Diabetes (GRADE) Study. Diabetes Care. 2013;36(8):2254-2261 (tel:2254-2261).

Barzilai N, et al. Cell Metabolism. 2016.

Kulkarni AS, et al. Cell Metabolism. 2020.

Campbell JM, et al. Ageing Research Reviews. 2017.

Bannister CA, et al. Diabetes, Obesity and Metabolism. 2014.

TAME Trial design paper (Clinical Geriatric Medicine, 2020).